Revolutionizing Gastrointestinal Pathogen Detection:  A Breakthrough in Real-Time RT-PCR Assay CEO PCR25

Revolutionizing Gastrointestinal Pathogen Detection: 

A Breakthrough in Real-Time RT-PCR Assays 

Diarrhea PCR25: 1 test 1 price 25 infections 

A breakthrough in gastrointestinal pathogen detection through the development of a multiplex real-time polymerase chain reaction (PCR) assay called CEO PCR25. 

• Diarrheal diseases are a significant global health concern caused by various pathogens.
• Conventional diagnostic methods face issues like variability, low sensitivity, and long turnaround times.
• Recent advancements in molecular diagnostics have led to the development of multiplex real-time PCR assays.

The RT-CEO PCR25

• The ART-CEO PCR25 is a multiplex one-step real-time reverse transcription PCR assay.
• It detects 6 viruses, 13 bacteria, and 6 parasites from a single stool specimen.
• Developed using Seegene's MuDT™ technology, providing multiple Ct values for precise analysis.

Key Features and Advantages

1. Broad Pathogen Coverage: Detects 25 different GI pathogens.
2. Short Turnaround Time (TAT): Results available in 4 hours from sample extraction.
3. Informative Data Output Provides individual Ct values for each pathogen for quantitative analysis.
4. Automated Data Interpretation:** Equipped with Seegene Viewer for streamlined result analysis and reporting.

Implications for Clinical Practice

• Rapid and accurate diagnosis of GI infections leading to timely interventions.
• Detailed quantitative data facilitates better patient management and disease surveillance.

Conclusion

• The CEO PCR25 offers a comprehensive and efficient solution for GI pathogen detection.
• Its short turnaround time, informative data output, and automated interpretation contribute to improved patient care and public health outcomes.

Overall, this breakthrough represents a significant advancement in molecular diagnostics, addressing the limitations of traditional methods and enhancing patient care in managing gastrointestinal infections. 

Analytes